+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lupus Drug"

Infliximab Drug Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Infliximab Drug Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Japan Interferons Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Interferons Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 80 Pages
  • Japan
From
Lupus Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Lupus Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • October 2023
  • 180 Pages
  • Global
From
Autoimmune Disease Testing Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Autoimmune Disease Testing Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 148 Pages
  • Global
From
Systemic Lupus Erythematosus Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update - Product Thumbnail Image

Systemic Lupus Erythematosus Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

  • Report
  • June 2023
  • 862 Pages
  • Global
From
Systemic Lupus Erythematosus and Lupus Nephritis Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Systemic Lupus Erythematosus and Lupus Nephritis Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • February 2023
  • 59 Pages
  • Global
From
Cutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Cutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • September 2023
  • 111 Pages
  • Global
From
Systemic Lupus Erythematosus and Lupus Nephritis: Global Drug Forecast and Market Analysis to 2027 - Product Thumbnail Image

Systemic Lupus Erythematosus and Lupus Nephritis: Global Drug Forecast and Market Analysis to 2027

  • Report
  • February 2020
  • 163 Pages
  • Global
From
Systemic Lupus Erythematosus - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 816 Pages
  • Global
From
US Systemic Lupus Erythematosus Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Systemic Lupus Erythematosus Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Systemic Lupus Erythematosus Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Systemic Lupus Erythematosus Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Systemic Lupus Erythematosus Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Systemic Lupus Erythematosus Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Intravenous Immunoglobulin Market by Application and Type: Global Opportunity Analysis and Industry Forecast, 2027 - Product Thumbnail Image

Intravenous Immunoglobulin Market by Application and Type: Global Opportunity Analysis and Industry Forecast, 2027

  • Report
  • July 2023
  • 179 Pages
  • Global
From
Systemic Lupus Erythematosus Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Systemic Lupus Erythematosus Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2024
  • 89 Pages
  • Global
From
Systematic Lupus Erythematosus Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Systematic Lupus Erythematosus Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 111 Pages
  • Global
From
Systemic Lupus Erythematosus Disease Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Systemic Lupus Erythematosus Disease Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • March 2025
  • 103 Pages
  • Global
From
Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 432 Pages
  • Global
From
Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 290 Pages
  • Global
From
Cutaneous Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Cutaneous Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 47 Pages
  • Global
From
Chronic Cutaneous Lupus Erythematosus - Discoid Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Chronic Cutaneous Lupus Erythematosus - Discoid Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 40 Pages
  • Global
From
Loading Indicator

The Lupus Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases such as lupus. Lupus is a chronic, autoimmune disorder that can cause inflammation, pain, and tissue damage in various parts of the body. Lupus drugs are used to reduce inflammation, suppress the immune system, and reduce the risk of organ damage. These drugs are typically prescribed in combination with other treatments such as lifestyle changes, physical therapy, and other medications. The Lupus Drug market is highly competitive, with a range of products available from both generic and branded manufacturers. Companies in the market include AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Pfizer, and Roche. Show Less Read more